BlogFile: Targacept, Inc. (TRGT)

May 13, 2007 · Filed Under blogfile, targacept 

BioHealth Investor.com

COMPANY BlogFILE
updated: May 13, 2007

TARGACEPT, Inc.

200 East First Street, Suite 300
Winston-Salem, NC 27101-4165
USA
Phone: (336) 480-2100
Fax: (336) 480-2107
www.targacept.com

Investor/Public Relations
Alan Musso
Vice President and Chief Financial Officer
(336) 480-2186
(336) 480-2103
alan.musso@targacept.com

COMPANY DESCRIPTION

Targacept, Inc. is a biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics™, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system. Our NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs.NNrs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.

BUSINESS INFORMATION

Public company
Ticker: TRGT
Market: NASDAQ
Industry: Biotechnology

LATEST BLOG COMMENTARY

Tiny Targacept Experiences Unusual Volume Surge
SeekingAlpha
April 18, 2007

Targacept: Late Day Volume Surge Deserves Attention
BioHealth Investor
April 17, 2007

Wednesday Pre-market Notes By Stock Ticker
SeekingAlpha
April 12, 2007

Barron’s Alzheimer’s Article Only Scratches the Surface
24/7 Wall St.
March 31, 2007

Friday’s Top Biotech and Medical Stocks
BioHealth Investor
November 04, 2007

Thursday’s Top Biotech and Medical Stocks
BioHealth Investor
November 02, 2006

Source: BioHealth Investor.com

___________________

Comments

Leave a Reply




    Subscribe to BioHealth Investor BioHealth Investor RSS Feed